Is Marksans Pharma Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Marksans Pharma Ltd (MARKSANS.NS) is currently classified as HALAL as of February 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Marksans Pharma Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Marksans Pharma Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Marksans Pharma Ltd?

Muslim investors may consider investing in Marksans Pharma Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Marksans Pharma Ltd classified as HALAL?

Musaffa determines the Shariah status of Marksans Pharma Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Marksans Pharma Ltd updated?

The Shariah compliance status of Marksans Pharma Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Marksans Pharma Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Marksans Pharma Ltd?

You can check the latest Shariah compliance status of Marksans Pharma Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

MARKSANS.NS Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: February 19, 2026

Report Source: 2026 3rd Quarter Report

Marksans Pharma Ltd. Stock Analysis MARKSANS.NS

India Health Care Small Cap Report: Q3, 2026

Marksans Pharma Ltd. engages in the research, manufacture, marketing, and sale of pharmaceutical formulations. The company operates two manufacturing facilities in Goa and maintains two research and development centers, one located in Goa and the other in Navi Mumbai. The firm's product portfolio spreads various therapeutic segments of the cardiovascular system (CVS), central nervous system (CNS), antidiabetic, pain management, cough and cold, gastroenterological, and anti-allergies. Its product portfolio includes tablets (plain, enteric-coated and film-coated), hard capsules, soft gelatin capsules, oral liquids and ointments. Its consumer self-care products (over-the-counter) include pain management, upper respiratory, digestive health, vitamins, minerals and supplements (VMS) and skin care products. Its prescription - Rx therapeutic segments include CVS, CNS, oncology, anti-diabetics and anti-biotic.

Key Statistics of Marksans Pharma Ltd (MARKSANS.NS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹200.05₹213.45

Today's Open

₹203.25

Volume

3.87M

P/E Ratio (TTM)

24.06

52 Week Range

₹155.00₹270.70

Market Cap

85.58B

Avg. Volume

1.77M

Dividend Yield

0.40%

Financial Metrics & Statements of Marksans Pharma Ltd (MARKSANS.NS)

FAQ's for Marksans Pharma Ltd (MARKSANS.NS)

According to Musaffa’s Shariah screening methodology, Marksans Pharma Ltd (MARKSANS.NS) is currently classified as HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.